383930 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
DT&CRO Co. Ltd. engages in the research and development of medicine and pharmaceuticals. It provides a full-service series of consignment studies ranging from non-clinical GLP toxicity, PK, and efficacy tests to analysis, livelihood, clinical trials, and licensing consultations required for licensing medicines, chemicals, health-function foods, cosmetics, and medical devices. The company was founded on April 3, 2017 and is headquartered in Yongin-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
383930 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company